Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas
- PMID: 7569019
- DOI: 10.1016/0167-8140(95)01534-n
Conventional radiotherapy combined with carbogen breathing and nicotinamide for malignant gliomas
Abstract
High grade malignant gliomas are among the most radioresistant human tumors and total doses up to 80 Gy are inadequate to achieve long-term local control in most of the patients. Hypoxia has been demonstrated in primary brain tumors and may be one of the reasons for their radioresistance. In experimental models carbogen breathing and nicotinamide have been shown to act against hypoxia by different mechanisms and both modalities were tested in 16 patients with supratentorial malignant gliomas in combination with a conventional radiotherapy scheme (50 Gy in 25 daily fractions). The present study was performed to determine the feasibility and toxicity of conventional radiotherapy combined with carbogen breathing and nicotinamide. The unexpectedly high incidence of acute liver toxicity, the possible increase of subacute and late CNS toxicity, and the absence of a higher effectivity led us to reconsider this new treatment modality for patients with malignant gliomas.
Similar articles
-
Accelerated radiotherapy, carbogen, and nicotinamide in glioblastoma multiforme: report of European Organization for Research and Treatment of Cancer trial 22933.J Clin Oncol. 1999 Oct;17(10):3143-9. doi: 10.1200/JCO.1999.17.10.3143. J Clin Oncol. 1999. PMID: 10506611 Clinical Trial.
-
Radiotherapy with carbogen breathing and nicotinamide in head and neck cancer: feasibility and toxicity.Radiother Oncol. 1995 Dec;37(3):190-8. doi: 10.1016/0167-8140(95)01660-0. Radiother Oncol. 1995. PMID: 8746587
-
Accelerated radiotherapy with carbogen and nicotinamide (ARCON) for laryngeal cancer.Radiother Oncol. 1998 Aug;48(2):115-22. doi: 10.1016/s0167-8140(98)00043-7. Radiother Oncol. 1998. PMID: 9783882
-
ARCON: a novel biology-based approach in radiotherapy.Lancet Oncol. 2002 Dec;3(12):728-37. doi: 10.1016/s1470-2045(02)00929-4. Lancet Oncol. 2002. PMID: 12473514 Review.
-
A therapeutic benefit from combining normobaric carbogen or oxygen with nicotinamide in fractionated X-ray treatments.Radiother Oncol. 1991 Oct;22(2):81-91. doi: 10.1016/0167-8140(91)90002-x. Radiother Oncol. 1991. PMID: 1835542 Review.
Cited by
-
Modification of loco-regional microenvironment in brain tumors by spinal cord stimulation. Implications for radio-chemotherapy.J Neurooncol. 2012 Jan;106(1):177-84. doi: 10.1007/s11060-011-0660-z. Epub 2011 Jul 12. J Neurooncol. 2012. PMID: 21748490
-
DNA damage and repair in tumour and non-tumour tissues of mice induced by nicotinamide.Br J Cancer. 1996 Aug;74(3):368-73. doi: 10.1038/bjc.1996.367. Br J Cancer. 1996. PMID: 8695350 Free PMC article.
-
Effect of breathing a hyperoxic hypercapnic gas mixture on the oxygenation of meningiomas; preliminary results.J Neurooncol. 2002 Apr;57(2):127-32. doi: 10.1023/a:1015732909712. J Neurooncol. 2002. PMID: 12125973
-
Gas Delivery Relevant to Human Health using Porous Materials.Chemistry. 2024 Sep 11;30(51):e202402163. doi: 10.1002/chem.202402163. Epub 2024 Aug 23. Chemistry. 2024. PMID: 38949770 Review.
-
The use of radiosensitizing agents in the therapy of glioblastoma multiforme-a comprehensive review.Strahlenther Onkol. 2022 Jun;198(6):507-526. doi: 10.1007/s00066-022-01942-1. Epub 2022 May 3. Strahlenther Onkol. 2022. PMID: 35503461 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical